Copy For Citation
Warrender-Sparkes M., Spelman T., Izquierdo G., Trojano M., Lugaresi A., Grand'Maison F., ...More
MULTIPLE SCLEROSIS JOURNAL, vol.22, no.4, pp.520-532, 2016 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
22
Issue:
4
-
Publication Date:
2016
-
Doi Number:
10.1177/1352458515594041
-
Journal Name:
MULTIPLE SCLEROSIS JOURNAL
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.520-532
-
Keywords:
Multiple sclerosis, disease-modifying therapy, fingolimod, medication persistence, MSBase, DISEASE-MODIFYING THERAPIES, INTERFERON-BETA THERAPY, TREATMENT PATTERNS, ADHERENCE, FINGOLIMOD, NATALIZUMAB
-
Karadeniz Technical University Affiliated:
Yes
Abstract
Objective: We aimed to analyse the effect of the introduction of fingolimod, the first oral disease-modifying therapy, on treatment utilisation and persistence in an international cohort of patients with multiple sclerosis (MS).